share_log

Lyell Immunopharma | SC 13G: Statement of acquisition of beneficial ownership by individuals-The Vanguard Group(5.05%)

Lyell Immunopharma | SC 13G:超过5%持股股东披露文件-The Vanguard Group(5.05%)

2023/02/09 11:25
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息